EXTON, Pa.--(BUSINESS WIRE)--Absorption Systems, a leader in testing drugs for ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity), today announced that the company has been awarded a $244,479.24 grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) program. The grant acknowledges the company’s CellPort Technologies® and its ability to help develop safe and effective drug combinations for the treatment of diseases such as cancer, diabetes, hyperlipidemia and HIV.
